Key Takeaways:
Lifeway Foods Inc. (Nasdaq: LWAY) announced a 37 percent year-over-year increase in net sales to a record $63.0 million for the first quarter ended March 31, 2026, driven by strong, volume-led demand for its flagship kefir products.
"We kicked off 2026 with a blowout quarter that demonstrates the extraordinary momentum we've built across our business," Julie Smolyansky, President and Chief Executive Officer of Lifeway Foods, said in a statement. "This exceptional top-line performance was accompanied by sizeable gross margin expansion of 360 basis points year-over-year, and equally strong net income growth of 32%."
The record-breaking results saw the company's gross profit margin climb to 27.5 percent. Net income rose to $4.7 million, or $0.31 per basic share, compared to $3.5 million, or $0.23 per share, in the same period last year. The company did not provide a comparison against consensus estimates in its release.
Lifeway's performance reflects a widening consumer focus on health and wellness, including a growing awareness of gut health and demand from users of GLP-1 drugs seeking nutrient-dense foods. The company produces the leading brand of kefir, a fermented probiotic drink, along with high-protein farmer cheese. It has also expanded its product pipeline with innovations like Muscle Mates with creatine and a probiotic Kefir Butter.
The company reiterated its long-term target of $45–$50 million in Adjusted EBITDA for fiscal year 2027 and stated it is positioned to deliver the strongest annual sales in its history in 2026. Investors will watch to see if the sales momentum can be sustained through the rest of the year as Lifeway continues its marketing and capacity investments.
This article is for informational purposes only and does not constitute investment advice.
